Skip to main content
Aegea begins post-market endometrial ablation tech study
10/31/2018

Aegea Medical is beginning a post-market study to evaluate the effects of its Adaptive Vapor Ablation technology in endometrial ablation procedures for three to four years post-treatment. The study will include up to 50 women who previously participated in the pivotal trial and will assess uterine cavity access and the feasibility of diagnostic and therapeutic interventions.

Full Story: